American Society of Hirudotherapy

Vascular venous anatomy of the calcaneal fillet flap for tibial stump reconstruction: Anatomical study focused on reduction of vascular complications

Research article published in Journal of hand and microsurgery (2025)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportSafety & Infection ControlCrosio et al. · Journal of hand and microsurgery, 2025

Abstract

INTRODUCTION: Traumatic lower-limb amputations and severe leg injuries may necessitate below-knee amputation when replantation or reconstruction is not feasible. In these situations, tibial bone and soft tissue may be insufficient to preserve the knee. The use of tissue from the amputated part, particularly the foot fillet flap, can allow knee salvage with significant functional benefit. The foot fillet flap is a composite flap that can be designed as pedicled or free, depending on injury characteristics. However, venous insufficiency remains a potential complication. This study investigated the venous drainage of the flap using cadaveric specimens. MATERIALS AND METHODS: Five fresh-frozen lower limbs were prepared and injected with colored latex into both the superficial and deep venous systems. Flaps were then dissected to analyze venous drainage pathways. RESULTS: Injection of the superficial system demonstrated that medial and lateral dorsal skin territories were not interconnected. Both territories showed perforating connections with the anterior tibial veins. Additional connections were identified between the deep system and the peroneal veins. These findings indicate that in large foot fillet flaps, approximately 230 cm2 in size, reliable venous drainage requires inclusion of both the medial system (great saphenous vein or tibial veins) and the small saphenous vein. Alternatively, the anterior tibial veins may provide sufficient outflow, as they appear capable of collecting venous blood from both systems. CONCLUSIONS: For extensive foot fillet flaps, optimal venous drainage can be achieved either by combining medial and lateral systems or by utilizing the anterior tibial veins. From a practical perspective, extending the plantar and medial ankle skin-territories drained by the posterior tibial and great saphenous veins-may allow reliance on a single venous system, thereby reducing the risk of venous congestion.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Summary

Peer-reviewed research on safety and infection-control considerations relevant to leech therapy and anticoagulation. Indexed in PubMed and verified against the NCBI record.

Why This Matters for Hirudotherapy

This cadaveric anatomical study examined the venous drainage pathways of foot fillet flaps used in tibial stump reconstruction, analyzing five latex-injected lower-limb specimens to determine which venous systems must be included for reliable outflow. For ASH and hirudotherapy, this work is relevant because venous congestion is a recognized complication of composite flaps in reconstructive surgery, and medicinal leech therapy is an established salvage measure when venous insufficiency threatens flap viability. Understanding the drainage architecture of these flaps helps clinicians anticipate congestion risk—precisely the clinical scenario in which leech-mediated venous decompression may be deployed. An honest caveat is that this is a small cadaveric study (five limbs) describing injection-based anatomy; it does not demonstrate clinical outcomes or in vivo venous dynamics.

Citation

Vascular venous anatomy of the calcaneal fillet flap for tibial stump reconstruction: Anatomical study focused on reduction of vascular complications.

Crosio et al. · Journal of hand and microsurgery, 2025

Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.